Drug Discovery Alliances in India-Indications, Targets, and New Chemical Entities

被引:5
|
作者
Differding, Edmond [1 ]
机构
[1] Differding Consulting Sprl, B-1348 Louvain, Belgium
关键词
drug discovery; Indian biotechnology; medicinal chemistry; research alliance; POTENT; ANTAGONISTS; INHIBITORS; CHINA;
D O I
10.1002/cmdc.201300341
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Global pharmaceutical and biotechnology companies have been building increasingly on the skills and services offered by Indian biotech companies through strategic collaborative partnerships and alliances to fuel their in-house discovery and development pipelines. With the exception of generic press releases, however, very little has been published on the process and progress of drug discovery itself, such as the targets or modes of action involved, nor on the scientific output of such collaborations, and therefore on new chemical entities coming out of India through research collaborations. This Essay provides an analytical review of recent patents, patent applications, and peer-reviewed publications of major research alliances. It aims at highlighting their scientific output as well as the considerable bandwidth of targets and therapeutic areas involved.
引用
收藏
页码:43 / 60
页数:18
相关论文
共 22 条
  • [1] Targeting autophagy drug discovery: Targets, indications and development trends
    Jiang, Mengjia
    Wu, Wayne
    Xiong, Zijie
    Yu, Xiaoping
    Ye, Zihong
    Wu, Zhiping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 267
  • [2] COVID-19: molecular targets, drug repurposing and new avenues for drug discovery
    Senger, Mario Roberto
    Santos Evangelista, Tereza Cristina
    Dantas, Rafael Ferreira
    da Silva Santana, Marcos Vinicius
    Saramago Goncalves, Luiz Carlos
    de Souza Neto, Lauro Ribeiro
    Ferreira, Sabrina Baptista
    Silva-Junior, Floriano Paes
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2020, 115 : 1 - 32
  • [3] Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets
    dos Santos Fernandes, Guilherme Felipe
    Jornada, Daniela Hartmann
    de Souza, Paula Carolina
    Chin, Chung Man
    Pavan, Fernando Rogerio
    dos Santos, Jean Leandro
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (27) : 3133 - 3161
  • [4] Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
    Singh, Vinayak
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [5] Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery
    Smith, Danielle
    Sadagopan, Nalini
    Zientek, Michael
    Reddy, Anita
    Cohen, Lucinda
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2): : 455 - 463
  • [6] Cancer Metabolism: New Validated Targets for Drug Discovery
    Sotgia, Federica
    Martinez-Outschoorn, Ubaldo E.
    Lisanti, Michael P.
    ONCOTARGET, 2013, 4 (08) : 1309 - 1316
  • [7] PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
    Guedeney, Nicolas
    Cornu, Marie
    Schwalen, Florian
    Kieffer, Charline
    Voisin-Chiret, Anne Sophie
    DRUG DISCOVERY TODAY, 2023, 28 (01)
  • [8] The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate
    Ogbourne, Steven M.
    Parsons, Peter G.
    FITOTERAPIA, 2014, 98 : 36 - 44
  • [9] Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
    Salomone, Salvatore
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [10] Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?
    Dunlop, John
    Brandon, Nicholas J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (02) : 230 - 238